跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Glemont L - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Glemont L
Approved
STANDARD
Glemont L
Glenmark Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7d9ee608ff641b52
Company
Glenmark Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
7d9ee608ff641b52
Drug Approval Philippines Name
Glemont L
Product Name
Glemont L
Registration Number
DRP-11971
Brand Name
Glemont L
Generic Name
Montelukast (as sodium) + Levocetirizine hydrochloride
Dosage Form
Film-Coated Tablet
Dosage Strength
10 mg/ 5 mg
Manufacturer
Glenmark Pharmaceuticals Limited
Importer
Glenmark Philippines, Inc.
Distributor
Glenmark Philippines, Inc.
Company Detail Path
/organization/glenmark-pharmaceuticals-limited
Issuance Date
25 May 2022
Expiry Date
25 May 2027
Pharmacologic Category
Leukotriene Receptor Antagonist-Antihistamine Combination
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7d9ee608ff641b52
Type
Standard
Back to Philippines FDA Approvals